17th-20th September 2024
Neutrophil 2024
- Prof Jesmond Dalli presented a poster entitled: Identifying neutrophil-derived molecular cues directing innate responses during bacterial infections
1st-4th September 2024
7th European Congress of Immunology
- Prof Jesmond Dalli co-chaired the Resolution of Inflammation session
2nd-5th July 2024
International Vascular Biology Meeting 2024
- Prof Jesmond Dalli presented a poster entitled: Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease in inflammatory arthritis
26th-28th June 2024
9th European Workshop on Lipid Mediators
- Dr Duco Koenis presented a poster entitled: Efferocyte-derived MCTRs prime macrophages for continual efferocytosis via Rac1-mediated activation of glycolysis
24th-26th June 2024
EFIS-iiSIAR forum Poznan.
- Prof Jesmond Dalli presented a talk entitled: MCTRs Regulate Macrophage Pro-resolving and Tissue Reparative Functions
13th-15th May 2024
EpiLipidNet Meeting Dresden
- Prof Jesmond Dalli presented a talk entitled: A Frameshift Variant in the Maresin 1 Receptor LGR6 Alters Human Phagocyte Responses and Increases Disease Incidence
- Ms Amitis Saliani presented a poster entitled: Evaluation of different integration and signal to noise algorithms on lipid mediator identification
- Mr Matthew Dooley presented a poster entitled: Development and validation of a high sensitivity method for the identification and quantitation of specialized pro-resolving mediators and classical eicosanoids.
8th May 2024
1st EFIS forum on innate immunity in Sterile Inflammation, Autoimmunity, and their Resolution
- Prof Jesmond Dalli presented a talk entitled: Utilizing Pro-Resolving Pathways for Treating Co-Morbidities
20th-23rd of March 2024
2024 European Phagocyte Workshop
- Prof Jesmond Dalli presented a talk entitled: Apoptotic cell uptake triggers localized MCTR production by macrophages to drive efferocytosis and tissue repair
- Dr Esteban Gomez presented a talk entitled: A frame shift mutation in LGR6 Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes and is linked with increased incidence of cardiovascular disease
23rd February 2024
CARIM Cardiovascular researcht institute & Maastricht University/University Medical Centre
- Prof Jesmond Dalli presented a talk for Cardiovascular Grand Rounds entitled: Resolving cardiovascular diseases – what is the evidence?
15th-16th January 2024
Second Meeting of the UK Neutrophil Network
- Prof Jesmond Dalli attended the meeting
26th-28th April 2023
3rd Resolution Days
- Prof Jesmond Dalli presented Insights Into The Biology Of Specialized Pro-resolving Mediators And Their Receptors In Phagocytes
- Mr Esteban Gomez presented A frame shift mutation in LGR6 Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes and is linked with increased incidence of cardiovascular disease
15th March 2023
BIORSP_2023
- Prof Jesmond Dalli presented SPM are functional biomarkers for omega-3 supplements
12th-14th December 2022
10th Cardiovascular Research Days & 28th Krakow Conference on Endothelium
- Prof Jesmond Dalli presented N-3 Docosapentaenoic Acid Resolvins In Vascular Protection
1st November 2022
Bioactive Lipids in Cancer, Inflammation and Related Diseases 2022
- Prof Jesmond Dalli presented Promoting tissue repair by reprogramming immune cells
- Mr Esteban A Gomez presented Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes
- Ms Roberta De Matteis presented Aspirin Triggered Specialised Pro-Resolving lipid mediators reprogram T cell and macrophage responses in colitis-associated colorectal cancer
9th – 12th of June 2022
31st Nordic Lipidforum Symposium 2022
- Prof Jesmond Dalli presented Specialised Pro-resolving Mediators Convey The Immune Regulatory Activities Of Omega-3 Fatty Acids
1st-4th May 2022
2022 AOCS Annual Meeting & Expo
Prof Jesmond Dalli presented Structure elucidation and biological evaluations of sulfido-conjugated specialized pro-resolving mediators
8th-10th March 2022
10th International Singapore Lipid Symposium
- Prof Jesmond Dalli presented Structure elucidation and biological evaluations of n-3 docosapentaenoic acid-derived 13-series Resolvins
February 2022
GOED Exchange
- Prof Jesmond Dalli presented Specialised Pro-resolving Mediators Convey The Immune Regulatory Activities Of Omega-3 Fatty Acids
16th September 2022
Ambiotis 15th Anniversary Celebrations
- Professor Jesmond Dalli presenting Reprogramming Immune Cells as a Novel Therapeutic Approach
4th-6th November 2021
Turkish Pharmacology Society meeting
- Professor Jesmond Dalli presenting Resolution of pathways as a novel therapeutic targets in cardiovascular diseases
9-10 September 2021
Lipid Mediators in Brain Diseases Symposium, Hasselt, Belgium
- Professor Jesmond Dalli presenting Specialised pro-resolving mediators as modulators of innate and adaptive immunity
25 June 2021
ICBL Webinar – Lipid Mediators in Inflammation
- Professor Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
27th-30th April 2021
Experimental Biology 2021
- Professor Jesmond Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
22 November 2019
The London Metabolomics Network Autumn meeting
- Professor Jesmond Dalli presenting Establishing a role for immunoresolvents in the maintenance of homeostasis and as diagnostic markers in patient stratification
20 – 23 October 2019
Bioactive Lipids in Cancer, Inflammation and Related Diseases 16th International Conference, St. Petersburg, Florida
- Professor Jesmond Dalli presenting Insights mechanisms elicited by immunoresolvants in the maintenance of homeostasis and the termination of inflammation, Tuesday 22 October
- Dr Romain Colas presenting Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis, Monday 21 October
- Mr Issa Beegun presenting Maresin 1 regulates peripheral leukocyte responses in patients with chronic eosinophilic nasal polyposis, Monday 21 October
- Ms Roberta De Matteis presenting Pro-resolving mediators mediate the protective actions of aspirin in colitis associated colorectal cancer, Monday 21 October
- Dr Patricia Soares De Souza presenting Enriched marine oil supplements increase peripheral blood SPM concentrations and reprogram host immune responses: A randomized double-blind placebo-controlled study, Monday 21 October
- Mr Esteban Gomez Cifuentes presenting Identification of pro-resolving mediators-based predictive biomarkers to DMARD responsiveness in rheumatoid arthritis, Monday 21 October
- Dr Duco Koenis presenting RvD5n-3 DPA engages GPR101 to promote the resolution of inflammatory arthritis and Escherichia coli infections, Tuesday 22 October
- Dr Lucy Ly presenting MCTR1, MCTR2, and MCTR3 resolve inflammation and protect joints in Inflammatory Arthritis, Monday 21 October
30 September – 2 October 2019
15th GERLI international Lipidomics meeting, Compiègne, France
16 October 2019
William Harvey Day, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
- Dr Romain Colas poster presentation, Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis
24-27 January 2019
Banff Inflammation Workshop, Banff, Alberta, Canada,
- Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotctive and mediate the actions of statins in controlling inflammation
- Dr Romain Colas presenting Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
- Dr Patricia Soares De Souza poster presentation of 13-Series Resolvins Mediate the Leukocyte-Platelet Actions of Atorvastatin and Pravastatin in Inflammatory Arthritis
- Ms Mary Walker poster presentation of RvT4 Reduces Joint Oedema and Atherosclerosis during Inflammatory Arthritis
18-20 December 2018
The British Pharmacological Society Pharmacology 2018, London,
- Dr Patricia Soares De Souza poster presentation of Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
12-14 September 2018
7th European Workshop on Lipid Mediators, Brussels,
- Dr Jesmond Dalli, giving two presentations: Profiling the resolution metabolome: considerations and methodologies and Functional Lipid Mediator Profiling in Establishing Disease Etiopathogenesis
- Dr Patricia Soares De Souza presenting the poster Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
- Ms Kim Pistorius presenting at the Young Investigator Session PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function
- Ms Mary Walker presenting at the Young Investigator Session 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
11-13 December 2017
Pharmacology 2017, London,
- Ms Kim Pistorius presenting PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function
- Ms Mary Walker presenting 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
22-25 October 2017
Bioactive Lipids in Cancer, Inflammation and Related Diseases, Puerto Vallarta, Mexico,
- Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotective and mediate the actions of statins in controlling inflammation
September 2017
UK Life Science and Medicine Summit, Beijing,
- Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections?
September 2017
Eurpoean Shock Society, Paris,
- Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections?
June 2017
World Congress on Inflammation, Solna,
- Dr Jesmond Dalli presented Immunoresolvants are regulated by the brain and control host responses to infections and tissue regeneration
May 2017
Meeting of the Minds, Royal Society, London,
- Dr Jesmond Dalli presented ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control
January 2017
Biochemical Society, Birmingham,
- Dr Jesmond Dalli presented Maresin conjugates in tissue regeneration promote the clearance of bacterial infections and are organ protective
December 2016
BSI 2016, Liverpool,
- Dr Jesmond Dalli presented ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control
July 2016
Physiology 2016, Dublin,
- Dr Jesmond Dalli presented Elucidation of Thirteen Series Resolvins that Regulate Host Responses in Infections
June 2016
LBMSDG, London,
- Dr Jesmond Dalli presented LC-MS/MS Based Structure Elucidation Of Novel Bioactive Mediators And Functional Lipid Mediator Profiling
May 2016
BSI London Immunology Showcase,
- Dr Jesmond Dalli presented Omega-3-fatty acids in inflammatory resolution and organ protection: Specialized Pro-resolving Mediators
April 2016
OARSI, Amsterdam,
- Dr Jesmond Dalli presented Lipid Mediators and the Resolution of Chronic Inflammation: Implications for Arthritis Therapy
- Prof Jesmond Dalli presented a poster entitled: Identifying neutrophil-derived molecular cues directing innate responses during bacterial infections
1st-4th September 2024
7th European Congress of Immunology
- Prof Jesmond Dalli co-chaired the Resolution of Inflammation session
2nd-5th July 2024
International Vascular Biology Meeting 2024
- Prof Jesmond Dalli presented a poster entitled: Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease in inflammatory arthritis
26th-28th June 2024
9th European Workshop on Lipid Mediators
- Dr Duco Koenis presented a poster entitled: Efferocyte-derived MCTRs prime macrophages for continual efferocytosis via Rac1-mediated activation of glycolysis
24th-26th June 2024
EFIS-iiSIAR forum Poznan.
- Prof Jesmond Dalli presented a talk entitled: MCTRs Regulate Macrophage Pro-resolving and Tissue Reparative Functions
13th-15th May 2024
EpiLipidNet Meeting Dresden
- Prof Jesmond Dalli presented a talk entitled: A Frameshift Variant in the Maresin 1 Receptor LGR6 Alters Human Phagocyte Responses and Increases Disease Incidence
- Ms Amitis Saliani presented a poster entitled: Evaluation of different integration and signal to noise algorithms on lipid mediator identification
- Mr Matthew Dooley presented a poster entitled: Development and validation of a high sensitivity method for the identification and quantitation of specialized pro-resolving mediators and classical eicosanoids.
8th May 2024
1st EFIS forum on innate immunity in Sterile Inflammation, Autoimmunity, and their Resolution
- Prof Jesmond Dalli presented a talk entitled: Utilizing Pro-Resolving Pathways for Treating Co-Morbidities
20th-23rd of March 2024
2024 European Phagocyte Workshop
- Prof Jesmond Dalli presented a talk entitled: Apoptotic cell uptake triggers localized MCTR production by macrophages to drive efferocytosis and tissue repair
- Dr Esteban Gomez presented a talk entitled: A frame shift mutation in LGR6 Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes and is linked with increased incidence of cardiovascular disease
23rd February 2024
CARIM Cardiovascular researcht institute & Maastricht University/University Medical Centre
- Prof Jesmond Dalli presented a talk for Cardiovascular Grand Rounds entitled: Resolving cardiovascular diseases – what is the evidence?
15th-16th January 2024
Second Meeting of the UK Neutrophil Network
- Prof Jesmond Dalli attended the meeting
26th-28th April 2023
3rd Resolution Days
- Prof Jesmond Dalli presented Insights Into The Biology Of Specialized Pro-resolving Mediators And Their Receptors In Phagocytes
- Mr Esteban Gomez presented A frame shift mutation in LGR6 Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes and is linked with increased incidence of cardiovascular disease
15th March 2023
BIORSP_2023
- Prof Jesmond Dalli presented SPM are functional biomarkers for omega-3 supplements
12th-14th December 2022
10th Cardiovascular Research Days & 28th Krakow Conference on Endothelium
- Prof Jesmond Dalli presented N-3 Docosapentaenoic Acid Resolvins In Vascular Protection
1st November 2022
Bioactive Lipids in Cancer, Inflammation and Related Diseases 2022
- Prof Jesmond Dalli presented Promoting tissue repair by reprogramming immune cells
- Mr Esteban A Gomez presented Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes
- Ms Roberta De Matteis presented Aspirin Triggered Specialised Pro-Resolving lipid mediators reprogram T cell and macrophage responses in colitis-associated colorectal cancer
9th – 12th of June 2022
31st Nordic Lipidforum Symposium 2022
- Prof Jesmond Dalli presented Specialised Pro-resolving Mediators Convey The Immune Regulatory Activities Of Omega-3 Fatty Acids
1st-4th May 2022
2022 AOCS Annual Meeting & Expo
Prof Jesmond Dalli presented Structure elucidation and biological evaluations of sulfido-conjugated specialized pro-resolving mediators
8th-10th March 2022
10th International Singapore Lipid Symposium
- Prof Jesmond Dalli presented Structure elucidation and biological evaluations of n-3 docosapentaenoic acid-derived 13-series Resolvins
February 2022
GOED Exchange
- Prof Jesmond Dalli presented Specialised Pro-resolving Mediators Convey The Immune Regulatory Activities Of Omega-3 Fatty Acids
16th September 2022
Ambiotis 15th Anniversary Celebrations
- Professor Jesmond Dalli presenting Reprogramming Immune Cells as a Novel Therapeutic Approach
4th-6th November 2021
Turkish Pharmacology Society meeting
- Professor Jesmond Dalli presenting Resolution of pathways as a novel therapeutic targets in cardiovascular diseases
9-10 September 2021
Lipid Mediators in Brain Diseases Symposium, Hasselt, Belgium
- Professor Jesmond Dalli presenting Specialised pro-resolving mediators as modulators of innate and adaptive immunity
25 June 2021
ICBL Webinar – Lipid Mediators in Inflammation
- Professor Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
27th-30th April 2021
Experimental Biology 2021
- Professor Jesmond Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
22 November 2019
The London Metabolomics Network Autumn meeting
- Professor Jesmond Dalli presenting Establishing a role for immunoresolvents in the maintenance of homeostasis and as diagnostic markers in patient stratification
20 – 23 October 2019
Bioactive Lipids in Cancer, Inflammation and Related Diseases 16th International Conference, St. Petersburg, Florida
- Professor Jesmond Dalli presenting Insights mechanisms elicited by immunoresolvants in the maintenance of homeostasis and the termination of inflammation, Tuesday 22 October
- Dr Romain Colas presenting Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis, Monday 21 October
- Mr Issa Beegun presenting Maresin 1 regulates peripheral leukocyte responses in patients with chronic eosinophilic nasal polyposis, Monday 21 October
- Ms Roberta De Matteis presenting Pro-resolving mediators mediate the protective actions of aspirin in colitis associated colorectal cancer, Monday 21 October
- Dr Patricia Soares De Souza presenting Enriched marine oil supplements increase peripheral blood SPM concentrations and reprogram host immune responses: A randomized double-blind placebo-controlled study, Monday 21 October
- Mr Esteban Gomez Cifuentes presenting Identification of pro-resolving mediators-based predictive biomarkers to DMARD responsiveness in rheumatoid arthritis, Monday 21 October
- Dr Duco Koenis presenting RvD5n-3 DPA engages GPR101 to promote the resolution of inflammatory arthritis and Escherichia coli infections, Tuesday 22 October
- Dr Lucy Ly presenting MCTR1, MCTR2, and MCTR3 resolve inflammation and protect joints in Inflammatory Arthritis, Monday 21 October
30 September – 2 October 2019
15th GERLI international Lipidomics meeting, Compiègne, France
16 October 2019
William Harvey Day, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
- Dr Romain Colas poster presentation, Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis
24-27 January 2019
Banff Inflammation Workshop, Banff, Alberta, Canada,
- Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotctive and mediate the actions of statins in controlling inflammation
- Dr Romain Colas presenting Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
- Dr Patricia Soares De Souza poster presentation of 13-Series Resolvins Mediate the Leukocyte-Platelet Actions of Atorvastatin and Pravastatin in Inflammatory Arthritis
- Ms Mary Walker poster presentation of RvT4 Reduces Joint Oedema and Atherosclerosis during Inflammatory Arthritis
18-20 December 2018
The British Pharmacological Society Pharmacology 2018, London,
- Dr Patricia Soares De Souza poster presentation of Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
12-14 September 2018
7th European Workshop on Lipid Mediators, Brussels,
- Dr Jesmond Dalli, giving two presentations: Profiling the resolution metabolome: considerations and methodologies and Functional Lipid Mediator Profiling in Establishing Disease Etiopathogenesis
- Dr Patricia Soares De Souza presenting the poster Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
- Ms Kim Pistorius presenting at the Young Investigator Session PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function
- Ms Mary Walker presenting at the Young Investigator Session 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
11-13 December 2017
Pharmacology 2017, London,
- Ms Kim Pistorius presenting PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function
- Ms Mary Walker presenting 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
22-25 October 2017
Bioactive Lipids in Cancer, Inflammation and Related Diseases, Puerto Vallarta, Mexico,
- Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotective and mediate the actions of statins in controlling inflammation
September 2017
UK Life Science and Medicine Summit, Beijing,
- Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections?
September 2017
Eurpoean Shock Society, Paris,
- Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections?
June 2017
World Congress on Inflammation, Solna,
- Dr Jesmond Dalli presented Immunoresolvants are regulated by the brain and control host responses to infections and tissue regeneration
May 2017
Meeting of the Minds, Royal Society, London,
- Dr Jesmond Dalli presented ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control
January 2017
Biochemical Society, Birmingham,
- Dr Jesmond Dalli presented Maresin conjugates in tissue regeneration promote the clearance of bacterial infections and are organ protective
December 2016
BSI 2016, Liverpool,
- Dr Jesmond Dalli presented ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control
July 2016
Physiology 2016, Dublin,
- Dr Jesmond Dalli presented Elucidation of Thirteen Series Resolvins that Regulate Host Responses in Infections
June 2016
LBMSDG, London,
- Dr Jesmond Dalli presented LC-MS/MS Based Structure Elucidation Of Novel Bioactive Mediators And Functional Lipid Mediator Profiling
May 2016
BSI London Immunology Showcase,
- Dr Jesmond Dalli presented Omega-3-fatty acids in inflammatory resolution and organ protection: Specialized Pro-resolving Mediators
April 2016
OARSI, Amsterdam,
- Dr Jesmond Dalli presented Lipid Mediators and the Resolution of Chronic Inflammation: Implications for Arthritis Therapy
JDALLILAB 